
Sign up to save your podcasts
Or


Mark Altmeyer, founder and CEO of Arvelle Therapeutics, speaks with BioBoss host John Simboli. Hear Mark’s thoughts about leadership and how Arvelle is working to bring new solutions to people living with epilepsy and CNS disorders.
By John Simboli5
77 ratings
Mark Altmeyer, founder and CEO of Arvelle Therapeutics, speaks with BioBoss host John Simboli. Hear Mark’s thoughts about leadership and how Arvelle is working to bring new solutions to people living with epilepsy and CNS disorders.

3,064 Listeners

1,942 Listeners

1,096 Listeners

2,360 Listeners

947 Listeners

792 Listeners

123 Listeners

321 Listeners

6,062 Listeners

94 Listeners

10,026 Listeners

522 Listeners

153 Listeners

248 Listeners

182 Listeners